



Satellite cell content is specifically reduced in type II
skeletal muscle fibers in the elderly
Citation for published version (APA):
Verdijk, L. B., Koopman, R., Schaart, G., Meijer, K., Savelberg, H. H. C. M., & van Loon, L. J. (2007).
Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. American
Journal of Physiology : Endocrinology and Metabolism, 292, E151-E157.
https://doi.org/10.1152/ajpendo.00278.2006





Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.




Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 03 Nov. 2021
Satellite cell content is specifically reduced in type II
skeletal muscle fibers in the elderly
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Verdijk LB, Koopman R, Schaart G, Meijer K, Savelberg HH,
van Loon LJ. Satellite cell content is specifically reduced in type II
skeletal muscle fibers in the elderly. Am J Physiol Endocrinol
Metab 292: E151–E157, 2007. First published August 22, 2006;
doi:10.1152/ajpendo.00278.2006.—Satellite cells (SC) are essential
for skeletal muscle growth and repair. Because sarcopenia is associ-
ated with type II muscle fiber atrophy, we hypothesized that SC
content is specifically reduced in the type II fibers in the elderly. A
total of eight elderly (E; 76  1 yr) and eight young (Y; 20  1 yr)
healthy males were selected. Muscle biopsies were collected from the
vastus lateralis in both legs. ATPase staining and a pax7-antibody
were used to determine fiber type-specific SC content (i.e., pax7-
positive SC) on serial muscle cross sections. In contrast to the type I
fibers, the proportion and mean cross-sectional area of the type II
fibers were substantially reduced in E vs. Y. The number of SC per
type I fiber was similar in E and Y. However, the number of SC per
type II fiber was substantially lower in E vs. Y (0.044  0.003 vs.
0.080  0.007; P  0.01). In addition, in the type II fibers, the number
of SC relative to the total number of nuclei and the number of SC per
fiber area were also significantly lower in E. This study is the first to
show type II fiber atrophy in the elderly to be associated with a fiber
type-specific decline in SC content. The latter is evident when SC
content is expressed per fiber or per fiber area. The decline in SC
content might be an important factor in the etiology of type II muscle
fiber atrophy, which accompanies the loss of skeletal muscle with
aging.
sarcopenia; muscle stem cells; atrophy; metabolism
THE GRADUAL LOSS OF skeletal muscle mass with aging, or
sarcopenia, represents a major factor determining the decline in
functional capacity, mobility, and general health in the elderly.
Muscle mass represents a main determinant of muscle strength
and has been strongly associated with performance in activities
of daily living and the level of independence in the elderly (16,
36, 49). Much work has been devoted to describing the alter-
ations in skeletal muscle that occur with aging. The most
consistent findings have been the decline in the total number of
muscle fibers and the specific atrophy of the type II fibers, both
contributing to the loss of skeletal muscle mass (18, 28, 30). In
accordance, type II muscle fiber atrophy and necrosis have
been shown to result in a reduced (area) proportion of type II
muscle fibers in skeletal muscle tissue in the elderly (15,
28, 29).
Although the exact mechanisms that cause sarcopenia re-
main to be elucidated, the hypothesis that satellite cells could
play an important role in this age-related loss of skeletal
muscle mass has recently gained much interest. Satellite cells
(SC), or “muscle stem cells,” are the sole source for the
generation of new myonuclei in vivo in skeletal muscle tissue
(2, 34, 35). As such, SC seem to be essential for the repair and
hypertrophy of skeletal muscle tissue. Normally, SC lie quies-
cent between the basal lamina and the plasma membrane of
muscle fibers (32). On activation and subsequent proliferation,
the majority of these SC differentiate to form new myonuclei
that either fuse with existing fibers or generate new fibers,
while a small proportion returns to quiescence (24, 50).
Because SC are responsible for the maintenance of skeletal
muscle mass, a decrease in the number of SC or in their ability
to become activated and proliferate in response to anabolic
stimuli is likely to result in impaired skeletal muscle structure
and function (44). Although the latter has been speculated to
occur in sarcopenia, studies investigating the effects of aging
on skeletal muscle SC content in humans have been inconclu-
sive. Whereas some studies reported both a reduced number of
SC per muscle fiber and a smaller proportion of SC relative to
the number of myonuclei in the elderly (22, 38), other studies
have failed to observe such differences (15, 20, 40). Although
it has been reported that no differences exist in the number of
SC between type I and II muscle fibers in young adults (23), it
could be speculated that the specific type II muscle fiber
atrophy with aging is associated with a fiber type-specific
reduction in SC content. Such a fiber type-specific reduction in
SC content could represent an important factor in the etiology
of sarcopenia and might explain the apparent discrepancy in
the literature regarding the effects of aging on muscle fiber SC
content.
In the present study, we assessed skeletal muscle fiber
type-specific characteristics and fiber type-specific satellite cell
content in young and elderly men. Therefore, skeletal muscle
biopsy samples were taken from the vastus lateralis in both the
left and right legs of eight young (20  1 yr) and eight elderly
(76  1 yr) lean males. Immunohistological staining of muscle
cross sections was performed to assess muscle fiber type-
specific SC content and muscle fiber characteristics.
METHODS
Subjects. Eight elderly (76  1 yr) and eight young (20  1 yr),
body weight-matched, male volunteers with no history of participating
in any regular exercise program were recruited to participate in the
present study. Characteristics of subjects are shown in Table 1. All
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subjects were informed on the nature and possible risks of the
experimental procedures before their written informed consent was
obtained. This study was approved by the Medical Ethics Committee
of the Academic Hospital, Maastricht.
Pretesting. The medical histories of subjects were evaluated, and
an oral glucose tolerance test was performed at least 2 wk before the
start of the trials (1, 31). Subjects with orthopedic and/or cardiovas-
cular abnormalities or type 2 diabetes were excluded from participa-
tion. After selection for this study, maximal strength was assessed in
two one-repetition maximum (1-RM) strength tests on a leg press and
leg extension machine, respectively. First, a familiarization trial was
performed. Proper lifting technique was demonstrated and practiced
for each of the two lower limb exercises. Thereafter, maximum
strength was estimated using the multiple repetitions testing procedure
(33). In an additional session, at least 10 days before muscle biopsy
collection, each subject’s 1-RM was determined. After warming up,
the load was set at 90–95% of the estimated maximum strength and
increased after each successful lift until failure. A 3-min resting period
between subsequent attempts was allowed. A repetition was valid if
the subject was able to complete the entire lift in a controlled manner
without assistance.
The weight and height of subjects were measured, and leg volume
was determined as described previously (21). In short, leg circumfer-
ence and height were measured at seven different sites, dividing the
leg into six segments. The volume of each segment was calculated by
treating each segment as a truncated cone, using the anthropometric
measurements for determining the height and the surface areas of each
cone. All subjects were instructed to refrain from strenuous physical
activity for 3 days before muscle biopsy collection and to maintain
their normal habitual dietary intake. On the day before biopsy collec-
tion, a standardized meal was provided, and from 9:00 PM, subjects
remained fasted.
Muscle biopsies. After an overnight fast, subjects arrived at the
laboratory by car or public transportation at 8:00 AM. After 30 min of
supine rest, a basal venous blood sample was collected. After local
anesthesia, percutaneous needle biopsies (50–80 mg) were taken
from the vastus lateralis muscle 15 cm above the patella in both the
left and right legs of each subject (3). Any visible nonmuscle tissue
was removed from the biopsy samples, which were then frozen in
liquid nitrogen-cooled isopentane, embedded in Tissue-Tek (Sakura
Finetek, Zoeterwoude, The Netherlands), and stored at 80°C until
further analyses.
Immunohistochemistry. From all biopsies, 5-m-thick cryosections
were cut at 20°C and samples from the left and right leg of each
subject were mounted together on uncoated glass slides. Care was
taken to properly align the samples for cross-sectional fiber analyses.
Slides from elderly and young subjects were stained simultaneously to
ensure identical staining efficiency.
An ATPase staining was performed after acid preincubation to
determine muscle fiber type as described previously (5, 8, 9). Instead
of dehydration of the slides at the end of the ATPase staining
procedure (5), sections were stained with anti-laminin (polyclonal
rabbit anti-laminin; Sigma, Zwijndrecht, The Netherlands) and there-
after with the appropriate secondary antibody goat anti-rabbit IgG
AlexaFluor488 (Molecular Probes, Invitrogen, Breda, The Nether-
lands). Nuclei were stained with 4,6-diamidino-2-phenylindole
(DAPI; Molecular Probes), similar to the procedures described below.
At a pH of 4.45, we were able to differentiate between black (type I),
white (type IIa), and intermediate (type IIb/IIx) fibers (Fig. 1). The
assessment of muscle fiber typing at this pH was validated by staining
serial muscle cross sections of three young and three elderly subjects
with myosin heavy chain (MHC)-I and MHC-IIa antibodies [A4.840
and N2.261, respectively; Developmental Studies Hybridoma Bank
(DSHB), Iowa City, IA]. Because too few type IIb/IIx fibers were
present for reliable SC counts in some of the biopsies, SC content and
fiber characteristics were assessed in type I and type II muscle fibers
only.
Immunostaining for the detection of myocellular SC content was
performed on serial cross sections with both pax7 (mouse anti-pax7,
DSHB), which marks both quiescent and activated SC (43, 50), and
Fig. 1. Muscle fiber type analyses performed on muscle tissue collected from
elderly (A) and young (B) males by ATPase staining of muscle cross sections;
type I fibers are black, and type II fibers are white (IIa) or show intermediate
staining (IIb/IIx). Type II fibers are significantly smaller in the elderly vs. the
young.
Table 1. Subject characteristics
Young (n  8) Elderly (n  8)
Age, yr 201 761*
Weight, kg 73.73.2 75.52.1
Height, m 1.810.03 1.710.01*
BMI, kg/m2 22.51.1 25.70.7*
Leg volume, liters 9.40.4 8.20.3*
Hb A1c, % 5.00.2 5.70.1*
Basal glucose, mmol/l 5.30.1 5.40.2
Basal insulin, mU/l 12.81.1 10.21.5
HOMA-IR 3.00.3 2.50.4
1-RM leg extension, kg 1084 784*
1-RM leg press, kg 2047 1517*
Values are means  SE. BMI, body mass index; HOMA-IR, homeostasis
model assessment of insulin resistance (31); 1-RM, 1-repetition maximum.
*Significantly different compared with the young (P  0.05).
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CD56 (mouse anti-CD56; BD Biosciences, San Jose, CA), which has
been extensively used for SC determination in human muscle tissue
(10, 15, 22, 23). Because of superior staining efficiency when using
pax7, this marker was used for the quantification of SC in the present
study. After fixation for 5 min with acetone, slides were air-dried and
incubated for 60 min at room temperature with primary antibodies
directed against laminin (dilution 1:50) and pax7 (dilution 1:20),
diluted in 0.05% Tween-PBS. Slides were then washed for 3  5 min
in PBS before incubation for 60 min at room temperature with the
appropriate secondary antibodies, purchased from Molecular Probes.
Goat anti-rabbit IgG-AlexaFluor555 (dilution 1:200) and goat anti-
mouse IgG1-AlexaFluor488 (dilution 1:500) were diluted together
with DAPI (0.238 M) in 0.05% Tween-PBS to, respectively, stain
laminin in red, pax7 in green, and myonuclei in blue (Fig. 2). After
incubation, slides were again washed for 3  5 min in PBS and then
covered with cover glasses using Mowiol (Calbiochem, Amsterdam,
The Netherlands).
Although pax7 is essential for the specification of SC, it has been
reported that pax7 expression declines when SC ontogeny proceeds
into terminal differentiation (43, 50). As such, the use of pax7 staining
as a marker for SC content could theoretically lead to an underesti-
mation of total SC count. Therefore, we validated the use of pax7 by
simultaneously staining cross sections of three young and three
elderly subjects with pax7, CD56, and DAPI. In agreement with
earlier findings (37), 	96% of CD56-positive SC were also pax7
positive, with no differences between age groups. In the present study,
the term “satellite cells” (SC) refers to the number of SC that stained
positive for pax7.
Data analyses. All images were digitally captured, using both light
microscopy (ATPase) and fluorescence microscopy (laminin, pax7,
and DAPI) with a Nikon E800 combined light/fluorescence micro-
scope (Nikon Instruments Europe, Badhoevedorp, The Netherlands)
coupled to a Basler A113 C progressive scan color CCD camera with
a Bayer color filter. Epifluorescence signal was recorded using a
Texas Red excitation filter (540–580 nm) for laminin, an FITC
excitation filter (465–495 nm) for pax7, and a DAPI UV excitation
filter (340–380 nm) for the nuclei. Image processing and quantitative
analyses were done using Lucia 4.81 software package (Nikon). All
image recordings and analyses were performed by an investigator
blinded to the subject coding.
From the ATPase-stained slides, images were captured at 120
magnification. Laminin was used to determine cell borders, and for all
fibers within each image, type I (black) and type II (white and
intermediate) fibers were identified (Fig. 1). Within each image, the
number of fibers, the mean fiber cross-sectional area (CSA), the
number of myonuclei per fiber, and the mean fiber area per nucleus
(fiber CSA/no. of myonuclei) were measured for the type I and type
II fibers separately. As a measure of fiber circularity, form factors
were calculated using the formula (4
 CSA)/(perimeter)2. Fiber cir-
cularity was not different between the muscle cross sections from the
elderly vs. the young for any fiber type.
From the pax7-stained slides, images were captured at 240
magnification to allow clear determination of SC localization. Lami-
nin was used to visualize the cell borders. Fiber typing was deter-
mined by matching the serial ATPase-stained cross sections. SC were
determined in each fiber between the basal lamina and the plasma-
membrane and stained positive for both DNA (DAPI) and pax7 (see
Fig. 2 for example). The data were used to calculate the number of SC
per muscle fiber, the proportion of SC [no. of SC/(no. of SC  no. of
Fig. 2. Muscle fiber type analyses for satel-
lite cell (SC) content. A: laminin  DAPI 
pax7 staining. B: only pax7 staining. C:
DAPI  pax7 staining. Arrows indicate the
SC. D: ATPase staining from serial muscle
cross sections of images A–C; the marked
area represents the same area as shown in
A–C.
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myonuclei)], and the number of SC per fiber area (in mm2) for the
type I and type II muscle fibers separately.
Because there were no differences in muscle fiber type composition
and CSA of the type I and II fibers between muscle samples taken
from the left vs. the right leg, muscle fiber data were pooled from both
biopsies in each subject, resulting in a mean number of 401  32 and
507  69 individual muscle fibers being analyzed in the young and
elderly subjects, respectively. For SC count, 287  26 and 291  29
fibers were analyzed in the muscle samples collected in the young and
elderly subjects, respectively.
Statistics. All values are expressed as means  SE. Muscle char-
acteristics in muscle biopsies collected from the left and right legs
were analyzed using paired t-tests. General differences between el-
derly and young subjects were evaluated by independent t-tests. In
addition, fiber type-specific variables were analyzed using mixed-
model analyses with “age group” (young and elderly) as the between-
subjects factor and “fiber type” (type I and II) as the within-subjects
factor. In the case of significant interaction, between-group differ-
ences were analyzed for the different fiber types separately, and
within-group differences were analyzed for the young and elderly
separately. A P level of 0.05 was used to determine statistical
significance. All analyses were performed using SPSS version 11.5
(Chicago, IL).
RESULTS
Subjects. Subject characteristics are provided in Table 1.
Basal blood glucose and insulin levels and whole body insulin
sensitivity as assessed by the homeostasis model assessment of
insulin resistance (HOMA-IR) index (31) did not differ be-
tween groups. Blood Hb A1c concentrations were within a
normal range for both groups but were significantly greater in
the elderly. Muscle strength as assessed by 1-RM for both leg
press and leg extension was significantly lower in the elderly
(151  7 and 78  4 kg, respectively) vs. the young (204 
7 and 108  4 kg, respectively; P  0.001). The latter was
accompanied by a lower leg volume in the elderly compared
with the young. In accordance, leg volume was significantly
correlated with muscle strength (r  0.53; P  0.05).
Fiber characteristics. Fiber type composition was signifi-
cantly different between groups (Table 2). Type II muscle fiber
content was significantly lower in the elderly (47  3%) vs. the
young (57  3%; P  0.05). In addition, the percentage of
total muscle area occupied by type II fibers was also signifi-
cantly smaller in the elderly (42  4%) vs. the young (59 
3%; P  0.01). Type II, but not type I, muscle fiber CSA
differed significantly between groups, with mean type II mus-
cle fiber CSA being smaller in the elderly vs. the young
(4,451  396 vs. 6,126  393 m2, respectively; P  0.05)
(Table 2, Fig. 1). There was a significant interaction between
age group and fiber type CSA (P  0.05). In the young, fiber
CSA did not differ between fiber types. In contrast, in the
elderly muscle fiber CSA was significantly smaller in the type
II vs. the type I fibers (P  0.05; Table 2).
Myonuclei. In both the young and elderly, the number of
myonuclei per fiber was significantly higher in the type I
muscle fibers compared with the type II muscle fibers (Table
3). In accordance, the fiber area per myonucleus was smaller
for the type I vs. the type II muscle fibers. The number of
myonuclei per muscle fiber differed significantly between
groups for both the type I and II muscle fibers (Table 3). More
myonuclei were present per type I and II muscle fibers in the
elderly compared with the young (type I, 3.5  0.2 vs. 3.0 
0.2, and type II, 2.6  0.1 vs. 2.3  0.1, respectively; P 
0.01). For the fiber area per myonucleus, there was significant
interaction between age group and fiber type. Separate analysis
showed significant differences between groups, with the el-
derly showing a significantly smaller fiber area per myonucleus
in both the type I and II muscle fibers when compared with the
young, the latter difference being more pronounced in the type
II muscle fibers (Table 3; P  0.05).
SC. In type I muscle fibers, no differences were observed in
SC content, neither as the number of SC per fiber nor as the
number of SC per millimeter squared (mm2), between the
young and the elderly (Table 3). In addition, SC proportion in
type I fibers did not differ between the young and the elderly.
In contrast, in the type II muscle fibers, SC content was
significantly lower in the elderly vs. the young. The number of
SC per type II muscle fiber was significantly reduced in the
elderly when compared with the young (0.044  0.003 vs.
0.080  0.007, respectively, P  0.01; Fig. 3). The latter was
also evident when correcting for CSA, as the number of SC per
mm2 of type II muscle fiber was also significantly reduced in
the elderly compared with the young (9.7  1.0 vs. 12.6  0.9,
respectively; P  0.05). In accordance, SC proportion was
significantly different between groups, with SC representing
1.5  0.2% of nuclei in the elderly type II muscle fibers
compared with 2.9  0.4% in type II muscle fibers of the
young (P  0.01). For all SC variables, there was a significant
interaction between age group and fiber type. In the young, no
significant differences were observed for any of the SC char-
acteristics between the type I and II muscle fibers. In the
elderly, the number of SC per muscle fiber, the number of SC
per mm2 of muscle fiber, and the proportion of SC were
substantially lower in the type II vs. the type I muscle fibers
(Table 3 and Fig. 3).
DISCUSSION
In the present study, we confirm that both the proportion and
CSA of the type II skeletal muscle fibers are substantially
reduced in skeletal muscle tissue in the elderly. As far as we
know, this is the first report that shows that type II muscle fiber
atrophy in the elderly is associated with a specific reduction in
the number of SC in these fibers. The latter is evident when
expressed as number of SC per muscle fiber, as proportion of
SC relative to the total number of nuclei, or as number of SC
per muscle fiber area. This muscle fiber type-specific decline in
SC content might represent an important factor in the etiology
of sarcopenia.
Numerous studies have demonstrated that the age-related
loss of skeletal muscle mass is characterized by a reduction in
Table 2. Muscle fiber characteristics
Young Elderly
CSA, m2 %Fiber %CSA CSA, m2 %Fiber %CSA
Type I 5,589281 433 413 5,471227 533* 584*
Type II 6,126393 573 593 4,451396*† 473* 424*
Values are means  SE. CSA, fiber cross-sectional area; %CSA, %muscle
area occupied per fiber type. For CSA, a significant interaction between group
and fiber type was found. *Significantly different compared with the young
(P  0.05). †CSA significantly different compared with the type I muscle
fibers (within groups, P  0.05).
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the total number of muscle fibers and specific atrophy of the
type II muscle fibers (18, 29, 30, 45). The decline in maximal
strength with age has been attributed to this gradual loss of
skeletal muscle tissue, but other intrinsic changes, e.g., fiber
type shifts and reduced concentrations of contractile material,
could also contribute to this phenomenon (6, 12). Our data
seem to confirm earlier reports (26, 27, 48) showing a reduced
leg volume and muscle strength in the elderly vs. the young
(Table 1). Furthermore, at the muscle level, we observed a
significantly higher percentage of type I muscle fibers and the
specific atrophy of the type II muscle fibers in the elderly
(Table 2). These findings are consistent with previous reports
(15, 28, 45) and are likely responsible for the reduced muscle
strength in the elderly (Table 1).
Even though the changes in muscle fiber type composition
and morphology with aging have been described rather con-
sistently in the literature, there is still considerable debate on
the underlying mechanisms responsible for these changes. It
has been suggested that SC content in muscle plays an impor-
tant role in the age-related changes in skeletal muscle structure
and function (44). However, although this topic has received
much attention over the past 10 years (10, 15, 19, 20, 22, 38,
40, 41, 47), the exact changes in the SC pool that occur with
aging still remain unresolved. Two recent studies have reported
a decline in SC content with aging in the tibialis anterior (22)
and in the biceps and masseter muscle (38) in humans. In
contrast, other studies failed to observe such differences in
either SC proportion or the number of SC in muscle fibers
taken from the vastus lateralis muscle in young vs. elderly
subjects (15, 20, 40). The apparent discrepancy between these
findings might be attributed to differences in study design, e.g.,
selection of subject age, the number of fibers analyzed, and the
specific muscle group studied.
So far, studies investigating age-related differences in SC
content in human skeletal muscle have been limited to mixed
muscle fiber analyses. In contrast to the fiber type-specific
differences in SC content that have been consistently shown in
rodent muscle (17, 42, 44), Kadi et al. (23) recently reported no
differences in SC content between type I and II muscle fibers
in young adults. However, because sarcopenia is associated
with the specific atrophy of type II muscle fibers, we hypoth-
esized that fiber type differences in SC content might exist at
an older age. Therefore, in the present study, we determined
type I and II muscle fiber type-specific SC content in both
young and elderly men. In accordance with Kadi et al. (23), we
observed 0.075 SC per muscle fiber, with no differences
between the type I and II muscle fibers in the young subjects
(Table 3). Extending their findings and consistent with the
specific atrophy of type II muscle fibers with aging, we ob-
served a 44  6% lower SC content in the type II vs. type I
muscle fibers in the elderly. Furthermore, SC content in the
type II muscle fibers in the elderly was significantly lower
when compared with type II muscle fiber SC content in the
young (Table 3, Fig. 3). Notably, even when correcting for
fiber CSA, type II muscle fiber SC content was still signifi-
cantly lower in the elderly vs. the young (Table 3). These data
support the idea that SC content is strongly associated with
myofiber maintenance and imply that the age-related reduction
in type II muscle fiber SC content might represent an important
factor in the specific loss and atrophy of type II muscle fibers
with aging.
As stated in METHODS, we used pax7 staining to assess
muscle fiber type-specific SC content in skeletal muscle cross
sections. It should be noted that a slight proportion of SC may
be pax7 negative in vivo, i.e., those SC that are progressing
into terminal differentiation (43, 50). Therefore, we cross-
validated our data by double staining with anti-CD56 in a
subset of muscle samples. The vast majority of SC were both
CD56 and pax7 positive, with no differences between the
young and elderly (94.9 vs. 96.5%, respectively). As such, the
latter could not be responsible for the substantial differences in
skeletal muscle fiber SC content between groups.
Findings from several rodent (7, 39, 44) as well as human
studies (10, 25, 46) suggest that the abundance of SC within
skeletal muscle fibers represents an important factor determin-
ing the capacity for myofiber maintenance. On the other hand,
type II myofiber atrophy and a reduction in SC content might
also be caused by one and the same phenomenon, e.g., de-
creased neuronal input (13). In addition, Bonavaud et al. (4)
recently reported that myotubes formed by the fusion of human
SC from either fast or slow muscle fibers in vitro express both
fast and slow MHC isoforms. This finding would argue against
a direct causal link between type II fiber SC loss and atrophy,
as the loss of SC could theoretically be compensated for by
Fig. 3. SC content in type I and II muscle fibers in the young vs. the elderly.
*Significantly different compared with the young (P  0.01). #Significantly
different compared with the type I muscle fibers (P  0.01).
Table 3. Myonuclei and satellite cell characteristics
Type
(I vs. II) Young Elderly
Nuclei/fiber Type I 3.00.2 3.50.2*
Type II 2.30.1† 2.60.1*†
Fiber area/nucleus, m2 Type I 1,84971 1,56256*
Type II 2,549129† 1,760104*†
SC/fiber Type I 0.0710.006 0.0820.005
Type II 0.0800.007 0.0440.003*†
%SC Type I 2.40.1 2.40.2
Type II 2.90.4 1.50.2*†
SC/mm2 Type I 12.71.1 13.81.0
Type II 12.60.9 9.71.0*†
Values are means  SE. SC, satellite cells; %SC, SC proportion [no. of
SC/(no. of SC  no. of myonuclei)]. *Significantly different compared with
the young (P  0.05). †Significantly different compared with the type I muscle
fibers (within groups, P  0.05).
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incorporating SC progeny from type I fibers. However, the
latter has yet to be established, and one could argue that, in an
in vivo situation, where SC progeny generally fuse with exist-
ing fibers, expression of fast MHC isoforms by SC originating
from slow fibers might not occur.
Our data support the idea that SC abundance is an important
factor regulating myofiber size. In addition, the reduced SC
content in type II fibers in the elderly might attenuate their
response to anabolic stimuli, stressing the need for potent
interventions for reversing the loss of skeletal muscle mass and
function with aging. Nevertheless, a direct causal link between
SC loss and myofiber atrophy remains to be established.
Furthermore, qualitative changes (e.g., blunted SC activation)
likely play another important role in the impaired regenerative
capacity of skeletal muscle tissue with aging. As such, endo-
crine changes as well as changes in the local SC environment
with aging might also contribute to the loss of SC due to the
prevention of SC self-renewal (11, 14, 44). At this moment, we
can only speculate on the potential causes and clinical rele-
vance of qualitative and quantitative changes in skeletal muscle
fiber SC content with aging, and more research is warranted.
In conclusion, this study is the first to show that SC content
is specifically reduced in the type II muscle fibers in elderly
men. The latter is shown to be evident when SC content is
expressed as number of SC per fiber as well as number of SC
per fiber area. The fiber type-specific reduction in SC content
might represent an important regulatory factor in the loss of
skeletal muscle mass, structure, and function with aging.
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